Scholars Central

Research articlePublished 19 Apr 2017

Alteration of Cytokine Profiles Inhibits Efficacy of Silver Nanoparticle-based Neutralization of Arenaviruses

Authors: Nathan Elrod, Jeff Brady, Harold Rathburn, Janice L. Speshock

Tarleton State University, Department of Biological Sciences, Stephenville, TX, USA; Tarleton State University, Department of Wildlife, Sustainability, and Ecosystem Sciences, Stephenville, TX, USA; Texas A&M AgriLife Research and Extension Center, Stephenville, TX, USA

Toxicology: Open Access

Volume 3 · Issue 2 · Pages 1–6

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Arenaviruses are important pathogens that can cause hemorrhagic fever or meningoencephalitis. There is not an effective treatment targeting arenaviruses, which necessitates a search for therapies against this virus family, as well as others. Silver nanoparticles (Ag-NPs) have been shown to have effective antiviral activity in cell culture models against arenaviruses, and therefore it was hypothesized that they may make an effective therapeutic against viral meningitis. However, the silver nanoparticles interfered with normal cytokine profiles produced in response to the virus infection, which led to exacerbated pathology. Methods: Mice were infected with Tacaribe virus, a mouse-adapted arenavirus that causes lethal encephalitis. The virus was left untreated or treated with 10 nm Ag-NPs, which were demonstrated previously to inhibit virus replication in cell culture. Virus replication, brain pathology, and cytokine profiles (pro-inflammatory interleukins and type I interferons), as well as over morbidity and mortality were assessed in the mice with and without treatment. Results: Although the viral loads appeared to be reduced in the Ag-NP treated mice, mortality was observed in all virus-infected animals, regardless of whether or not they received nanoparticle therapy. The Ag-NP treatments also the innate immune response against the virus infection and unregulated the production of interleukin-1 beta, which likely contributed to the observed mortality in the mice. Conclusions: This study confirms why it is important to assess promising in vitro results using in vivo models. Biological barriers can impact the efficacy of therapeutics in mammals. Although Ag-NPs may still have success as an antiviral therapeutic in other areas of the body that are less constricted, in sensitive areas such as the brain, the nanoparticles can cause very adverse reactions.

Subjects

Toxicology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Toxicology: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalToxicology: Open Access
  • SubjectToxicology
  • BylineArticles whose byline prints “Nathan Elrod”
  • BylineArticles whose byline prints “Jeff Brady”
  • BylineArticles whose byline prints “Harold Rathburn”
  • BylineArticles whose byline prints “Janice L. Speshock”